Cimzia 200 mg lyophilized powder for injection Images

Generic Name: certolizumab

This medication has been identified as Cimzia 200 mg lyophilized powder for injection. It is supplied by UCB, Inc.

Cimzia is used in the treatment of Ankylosing Spondylitis; Crohn's Disease; Crohn's Disease, Active; Crohn's Disease, Maintenance; Non-Radiographic Axial Spondyloarthritis and belongs to the drug class TNF alfa inhibitors. There is no proven risk in humans during pregnancy. Cimzia 200 mg lyophilized powder for injection is not a controlled substance under the Controlled Substances Act (CSA).

Images of medication

Cimzia

Generic Name

certolizumab

Strength

200 mg lyophilized powder for injection

Availability

Prescription only

Drug Class

TNF alfa inhibitors

Pregnancy Category

B - No proven risk in humans

CSA Schedule

Not a controlled drug

Labeler / Supplier

UCB, Inc.

National Drug Code (NDC)

50474-0700

Drug Uses Add to Drug List Print

Get help with Imprint Code FAQs.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer